Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytokine-Induced Killer Cells”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02782546
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 60
Testing effectiveness (Phase 2)UnknownNCT01235845
What this trial is testing

Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma

Who this might be right for
Malignant Glioma
Qingdao University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02497898
What this trial is testing

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
The First People's Hospital of Changzhou 1,000
Not applicableUnknownNCT01498055
What this trial is testing

Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study

Who this might be right for
Lung Cancer
Third Military Medical University 120
Early research (Phase 1)Study completedNCT04802070
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Prof. Franca Fagioli 7
Testing effectiveness (Phase 2)UnknownNCT01655628
What this trial is testing

GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Stage IV Nasopharyngeal Carcinoma
Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT03124498
What this trial is testing

Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Who this might be right for
Hepatocellular Carcinoma
Chuan An Biotechnology Co., Ltd. 55
Early research (Phase 1)WithdrawnNCT03782363
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Italian Sarcoma Group
Testing effectiveness (Phase 2)Study completedNCT01894373
What this trial is testing

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Who this might be right for
PsoriasisAdoptive Immunotherapy
Chinese PLA General Hospital 10
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Early research (Phase 1)Study completedNCT00185757
What this trial is testing

Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Multiple MyelomaBlood and Marrow Transplant (BMT)
Stanford University 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02498756
What this trial is testing

Cytokine-induced Killer Study for Patients With Stage II Melanoma

Who this might be right for
Melanoma
The First People's Hospital of Changzhou 300
Large-scale testing (Phase 3)Study completedNCT02419677
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer
The First People's Hospital of Changzhou 60
Testing effectiveness (Phase 2)UnknownNCT01929499
What this trial is testing

Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer

Who this might be right for
Colonic Neoplasms
Yanjuan Zhu 210
Post-approval studies (Phase 4)UnknownNCT01758679
What this trial is testing

A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma

Who this might be right for
Multiple Drug Use
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)UnknownNCT03821519
What this trial is testing

Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant

Who this might be right for
Relapsed Hematologic Malignancy
A.O. Ospedale Papa Giovanni XXIII 20
Testing effectiveness (Phase 2)Study completedNCT00394381
What this trial is testing

Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome, High Grade
Singapore General Hospital 17
Early research (Phase 1)Looking for participantsNCT06152809
What this trial is testing

CIML NK Cells With Venetoclax for AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia RecurrentLeukemia+1 more
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)UnknownNCT02215837
What this trial is testing

Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer

Who this might be right for
Gastric CancerNeoplasmsGastrointestinal Neoplasms+2 more
Shenzhen Hornetcorn Bio-technology Company, LTD 40
Testing effectiveness (Phase 2)Study completedNCT01186809
What this trial is testing

Cytokine Induced Killer (CIK) Cells In Leukemia Patients

Who this might be right for
Hematologic Malignancies
A.O. Ospedale Papa Giovanni XXIII 74
Next Page